Search filters

List of works by Peppy Rebello

Blood concentrations of alemtuzumab and antiglobulin responses in patients with chronic lymphocytic leukemia following intravenous or subcutaneous routes of administration

scientific article

Insulin needs after CD3-antibody therapy in new-onset type 1 diabetes

scientific article

Neutralizing tumor necrosis factor activity leads to remission in patients with refractory noninfectious posterior uveitis

scientific article published in June 2004

Pharmacokinetics and antibody responses to the CD3 antibody otelixizumab used in the treatment of type 1 diabetes.

scientific article published on 10 February 2010

Phase II trial of subcutaneous anti-CD52 monoclonal antibody alemtuzumab (Campath-1H) as first-line treatment for patients with B-cell chronic lymphocytic leukemia (B-CLL).

scientific article

Paulina is supported by:

About Paulina

Help